Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.

Am J Respir Crit Care Med · 2020 · PMC7462391 · PMID 32186896

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

For benralizumab versus placebo in both the GALATHEA ( NCT02138916 ) and TERRANOVA ( NCT02155660 ) phase III trials, reduction in AER did not reach statistical significance for the primary analysis population with BEC ≥ 220 cells/μl ( 24 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.